MEDiThings was featured in a SparkLabs investor column highlighting the company’s mission to address the unmet needs of patients with bladder dysfunction and their caregivers.
The article introduced bladder dysfunction as a condition that can significantly affect daily life, especially for patients with spinal cord injury, Alzheimer’s disease, Parkinson’s disease, aging-related urinary issues, or neurological damage after surgery. These patients may have difficulty recognizing the need to urinate or emptying the bladder properly, often requiring scheduled urination or catheterization.
Because bladder filling can vary depending on fluid intake and other factors, patients and caregivers often face uncertainty around the right timing for urination or catheterization. Missing the appropriate timing may lead to urinary incontinence, urinary tract infections, and restrictions on daily activities.
The article described MEDiThings as a startup developing a wearable bladder monitoring solution to help patients, families, caregivers, and healthcare professionals better understand bladder status in daily life. The solution is designed to be worn on the lower abdomen and connected to a mobile application, allowing users to monitor bladder-related information more conveniently outside of hospital settings.
SparkLabs noted that MEDiThings was founded by Aram Kim, a urologist specializing in neurogenic bladder, and Sehwan Kim, a biomedical engineering professor with deep technical expertise. The article emphasized that the company was built around a clear clinical problem and a strong commitment to improving the lives of patients and caregivers.
The article also highlighted MEDiThings’ research and development progress, including published scientific research, exploratory clinical studies, and ongoing preparations for clinical and regulatory milestones in Korea and the United States.
SparkLabs first invested in MEDiThings in September 2022 and later recommended the company for the TIPS program. MEDiThings subsequently attracted bridge investment from Kakao Ventures and D.CAMP within six months of its first investment from SparkLabs.
The article concluded that MEDiThings represents the type of startup SparkLabs values: a capable team focused on solving a meaningful problem, rather than simply pursuing technology for its own sake. It described MEDiThings as a company with the potential to improve quality of life for patients with bladder dysfunction and their families around the world.
[Published: May 1, 2024]
Source: https://www.chosun.com/economy/smb-venture/2024/05/01/6WE7EHUCANB2XA2EVZVFK2CEAM/
MEDiThings was featured in a SparkLabs investor column highlighting the company’s mission to address the unmet needs of patients with bladder dysfunction and their caregivers.
The article introduced bladder dysfunction as a condition that can significantly affect daily life, especially for patients with spinal cord injury, Alzheimer’s disease, Parkinson’s disease, aging-related urinary issues, or neurological damage after surgery. These patients may have difficulty recognizing the need to urinate or emptying the bladder properly, often requiring scheduled urination or catheterization.
Because bladder filling can vary depending on fluid intake and other factors, patients and caregivers often face uncertainty around the right timing for urination or catheterization. Missing the appropriate timing may lead to urinary incontinence, urinary tract infections, and restrictions on daily activities.
The article described MEDiThings as a startup developing a wearable bladder monitoring solution to help patients, families, caregivers, and healthcare professionals better understand bladder status in daily life. The solution is designed to be worn on the lower abdomen and connected to a mobile application, allowing users to monitor bladder-related information more conveniently outside of hospital settings.
SparkLabs noted that MEDiThings was founded by Aram Kim, a urologist specializing in neurogenic bladder, and Sehwan Kim, a biomedical engineering professor with deep technical expertise. The article emphasized that the company was built around a clear clinical problem and a strong commitment to improving the lives of patients and caregivers.
The article also highlighted MEDiThings’ research and development progress, including published scientific research, exploratory clinical studies, and ongoing preparations for clinical and regulatory milestones in Korea and the United States.
SparkLabs first invested in MEDiThings in September 2022 and later recommended the company for the TIPS program. MEDiThings subsequently attracted bridge investment from Kakao Ventures and D.CAMP within six months of its first investment from SparkLabs.
The article concluded that MEDiThings represents the type of startup SparkLabs values: a capable team focused on solving a meaningful problem, rather than simply pursuing technology for its own sake. It described MEDiThings as a company with the potential to improve quality of life for patients with bladder dysfunction and their families around the world.
[Published: May 1, 2024]
Source: https://www.chosun.com/economy/smb-venture/2024/05/01/6WE7EHUCANB2XA2EVZVFK2CEAM/